• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Ang Share Price

    Ang Lifesciences India Share PriceANG Lifesciences India

    Small Cap 1.9k Result
    ₹65.02
    0.26 (0.4%)
    As on 11 December, 2023 | 23:52 BSE: 540694 NSE: ANGISIN: INE236W01016
    Bonus

    Ang Lifesciences India Performance

    Day Range

    • Low
    • High
    ₹ 65.02

    52 Week Range

    • Low
    • High
    ₹ 65.02
    • Open Price
    • Previous Close
    • Volume

    Start SIP in ANG Lifesciences India

    Start SIP

    Ang Lifesciences India Share Price

    • Over 1 Month -6.59%
    • Over 3 Month -12.48%
    • Over 6 Month -10.67%
    • Over 1 Year -49.69%

    Ang Lifesciences India Key Statistics

    Ang Lifesciences India Investment Rating

    • Master Rating:

    • Angel One has an operating revenue of Rs. 3,399.62 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 40% is great, ROE of 41% is exceptional. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 71% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 96 which is a GREAT score indicating consistency in earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Finance-Investment Mgmt and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    ANG Lifesciences India Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 30513245587296
    Operating Expenses Qtr Cr 28454343446084
    Operating Profit Qtr Cr 16-122141112
    Depreciation Qtr Cr 2232222
    Interest Qtr Cr 2213334
    Tax Qtr Cr 01-1-1232
    Net Profit Qtr Cr -22-5-2835
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 217350
    Operating Expenses Annual Cr 196284
    Operating Profit Annual in Cr 1165
    Depreciation Cr 95
    Interest Annual Cr 108
    Tax Annual Cr 313
    Net Profit Annual Cr -140
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2727
    Cash from Investing Activity Annual Cr -43-43
    Cash from Financing Annual Activity Cr 1515
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 8683
    Fixed Assets Annual Cr 7982
    Total Non Current Assets Annual Cr 8387
    Total Current Assets Annual Cr 170182
    Total Assets Annual Cr 253269
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 6681
    ROE Annual % -148
    ROCE Annual % 1253
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1019
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 33563947607495
    Operating Expenses Qtr Cr 32505044506283
    Operating Profit Qtr Cr 27-103101213
    Depreciation Qtr Cr 2232223
    Interest Qtr Cr 2223334
    Tax Qtr Cr 01-1-1232
    Net Profit Qtr Cr -22-5-2335
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 230355
    Operating Expenses Annual Cr 206287
    Operating Profit Annual in Cr 1467
    Depreciation Cr 96
    Interest Annual Cr 129
    Tax Annual Cr 313
    Net Profit Annual Cr 040
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2525
    Cash from Investing Activity Annual Cr -44-44
    Cash from Financing Annual Activity Cr 2020
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 8684
    Fixed Assets Annual Cr 8893
    Total Non Current Assets Annual Cr 9398
    Total Current Assets Annual Cr 187193
    Total Assets Annual Cr 280291
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 6681
    ROE Annual % 048
    ROCE Annual % 1250
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1119
    Invest in Ang Lifesciences India

    Ang Lifesciences India Technicals

    EMA & SMA

    Current Price
    ₹65.02
    0.26 (0.4%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹65.49
    • 50 Day
    • ₹67.51
    • 100 Day
    • ₹70.29
    • 200 Day
    • ₹81.64
    • 20 Day
    • ₹65.04
    • 50 Day
    • ₹68.31
    • 100 Day
    • ₹69.37
    • 200 Day
    • ₹73.72

    Ang Lifesciences India Resistance and Support

    PIVOT
    ₹65.87
    Resistance
    First Resistance 67.68
    Second Resistance 69.80
    Third Resistance 71.61
    RSI 47.87
    MFI 49.15
    MACD Single Line -1.32
    MACD -1.00
    Support
    First Resistance 63.75
    Second Resistance 61.94
    Third Resistance 59.82

    Ang Lifesciences India Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 18,679 1,270,359 68.01
    Week 12,201 709,976 58.19
    1 Month 14,991 991,371 66.13
    6 Month 16,356 1,143,763 69.93

    Ang Lifesciences India Result Highlights

    ANG Lifesciences India Synopsis

    NSE-Finance-Investment Mgmt

    Angel One belongs to the Industry of Finance & Investments. Company’s Total Operating Revenue is Rs. 2984.08 Cr. and Equity Capital is Rs. 83.42 Cr. for the Year ended 31/03/2023. Angel One Ltd. is a Public Limited Listed company incorporated on 08/08/1996 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L67120MH1996PLC101709 and registration number is 101709.
    Market Cap 25,008
    Sales 3,381
    Shares in Float 5.20
    No of funds 193
    Yield 1.07
    Book Value 11.77
    U/D Vol ratio 1.2
    LTDebt / Equity 1
    Alpha 0.25
    Beta 1.15

    ANG Lifesciences India

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 38.26%38.3%38.48%43.68%
    Mutual Funds 8.15%8.28%8%7.71%
    Insurance Companies 0.73%0.43%0.57%0.45%
    Foreign Portfolio Investors 16.4%14.35%13.31%13.95%
    Individual Investors 31.11%31.4%32.7%27.09%
    Others 5.35%7.24%6.94%7.12%

    ANG Lifesciences India Management

    Name Designation
    Mr. Dinesh D Thakkar Chairman & Managing Director
    Mr. Ketan Shah Whole Time Director
    Mr. Krishna Iyer Non Executive Director
    Ms. Mala Todarwal Ind. Non-Executive Director
    Mr. Muralidharan Ramachandran Ind. Non-Executive Director
    Mr. Krishnaswamy Arabadi Sridhar Ind. Non-Executive Director
    Mr. Kalyan Prasath Ind. Non-Executive Director

    Ang Lifesciences India Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Ang Lifesciences India Corporate Action

    Date Purpose Remarks
    2023-11-14 Quarterly Results
    2023-08-14 Quarterly Results
    2023-05-30 Audited Results
    2023-03-06 Preferential issue of shares
    2023-02-14 Quarterly Results
    Date Purpose Remarks
    2021-11-04 INTERIM Rs.1.00 per share(10%)Interim Dividend
    Date Purpose Remarks
    2022-07-14 Bonus Rs.0.00 issue in the ratio of 1:4 of Rs. 10/-
    2021-09-23 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-

    ANG Lifesciences India FAQs

    What is Share Price of ANG Lifesciences India ?

    ANG Lifesciences India share price is ₹65 As on 11 December, 2023 | 23:38

    What is the Market Cap of ANG Lifesciences India ?

    The Market Cap of ANG Lifesciences India is ₹84.9 Cr As on 11 December, 2023 | 23:38

    What is the P/E ratio of ANG Lifesciences India ?

    The P/E ratio of ANG Lifesciences India is -12.2 As on 11 December, 2023 | 23:38

    What is the PB ratio of ANG Lifesciences India ?

    The PB ratio of ANG Lifesciences India is 1 As on 11 December, 2023 | 23:38

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.